Home Blog Page 245

Rivers are Life Premieres ‘Wings of the Oder’ Bringing Awareness to Poland’s Oder River

By
NT Editor
-
0
Rivers are Life Premieres ‘Wings of the Oder’ Bringing Awareness to Poland’s Oder River

MIDLAND, Mich., August 18, 2023 (Newswire.com) - Tomorrow, August 19, Rivers are Life unveils the latest documentary highlighting the Oder River and conservation efforts made by local River Hero, Piotr Chara. Located in central Europe, the Oder River is Poland's second longest river, which runs from the Czech Republic, through Poland and Germany, and into the Baltic Sea. This film, titled "Wings of the Oder," centers on Piotr and his mission to protect the Oder and surrounding wildlife habitats while inspiring people locally and around the world. 

Piotr Chara spent most of his childhood in and around the Oder River and its shores. As he grew older and continued to watch, Piotr noticed a dramatic decline in the river and the local wildlife that called it home. Unintended consequences from a river widening project and the effects of climate change have played into the situation and negatively impacted the once thriving shores' delicate ecosystem.

Various species of Wetland birds are native to this area, such as little terns and oystercatchers. The number of birds migrating to the river were decreasing in high numbers due to difficulty nesting - their habitats were compromised which made them easy prey for local predators in the area. Piotr researched different solutions and created an organization that builds floating nests for the birds to be able to breed safely and comfortably. 

"The plight of these birds didn't allow me to rest. I admired their beauty, their grace, their mating dances," said Piotr Chara. "I was eventually able to recognize individual birds, to become familiar with their temperament and personal habits. I felt honored. It was all the more painful, then, to see their dramatic situation. I knew it was imperative to find the time, find a solution and resources to help them."

To date, Piotr's team has installed eight artificial nests to help the at-risk birds. Now an award-winning photographer, Piotr films the birds as part of his studies and reports his findings to The Green Valley of the Oder and Warta (ZDOW) Foundation. Since filming on this project began, Piotr and his loyal volunteers, along with The Green Valley of the Oder and the Warta (ZDOW) Foundation, worked together to officially achieve reservation status for the Oder River. This status will protect the river from any potential human threats, providing a thriving breeding ground for wildlife for years to come.

"Wings of the Oder" premieres August 19 and will be a reminder for just how essential our rivers are to communities and ecosystems across the globe.

Watch "Wings of the Oder" HERE.

Contact Information:
Julia Regeski
Impact Manager, BeAlive Inc.
[email protected]
404-578-7180


Original Source: Rivers are Life Premieres 'Wings of the Oder' Bringing Awareness to Poland's Oder River

Nushape Unveils the Therapy Mat: Your Ultimate Portable Partner for Holistic Wellness

By
NT Editor
-
0
Nushape Unveils the Therapy Mat: Your Ultimate Portable Partner for Holistic Wellness

LEWES, Del., August 18, 2023 (Newswire.com) - Nushape, a pioneer in holistic health solutions, is thrilled to introduce the therapy mat, a fusion of cutting-edge technology and user-centric design. This state-of-the-art device offers a cascade of therapeutic light that may help to soothe muscles1, alleviate discomfort and energize users for a productive day, all while ensuring wellness is always within reach.

Why the Therapy Mat is a Game-Changer:

Beyond its transformative benefits, the Therapy Mat stands out for its portability and ease of use. Lightweight and as easy to roll up as a yoga mat, it comes with a travel bag, ensuring you never miss out on your wellness routine, whether you're at home, in a hotel, or on a retreat.

Key Features:

  • Versatile Applications: From skin rejuvenation2 to muscle recovery3, the Therapy Mat offers tailored sessions that may help pain alleviation, inflammation reduction4, body energizing, and more.
  • Innovative Design: With its 1,408 high-powered LED lights operating at wavelengths of 660nm and 850nm, it reaches deep skin layers that may help by stimulating cellular repair, increasing circulation, and promoting a youthful complexion2 .
  • Portability Perfected: Sized at 63 x 27.5 inches, it's incredibly easy to use. Roll it, pack it in its travel bag and embark on your wellness journey wherever you go.

Jessica Charles, CEO & founder of Nushape, shares, "The Therapy Mat is more than just a product; it's a holistic wellness solution. We envisioned a mat that not only caters to diverse wellness needs but also fits seamlessly into modern lifestyles."

The Therapy Mat offers three distinct programs:

  • Enhance your body and soothe discomfort: Deeply penetrates the skin, potentially accelerating recovery5 and may offer benefits like skin rejuvenation2 and metabolism improvement6.
  • Recovery Mode: Continuous red light and pulsed Near-Infrared light at 10 hertz, designed to support the body's natural recovery processes.
  • Energy Mode: Continuous red light and pulsed NIR light at 40 hertz, may potentially increase dopamine and serotonin levels7 , that may help promote well-being and energy.

Discover the Future of Portable Wellness:

Leading the charge in innovative wellness solutions, Nushape is committed to products that resonate with today's dynamic lifestyles. The Therapy Mat is a testament to this commitment, blending efficacy with convenience. Experience the transformative power of the Therapy Mat and its myriad benefits. Dive deeper at www.nushape.com. 

About Nushape:

Nushape, the creator of Red Light Therapy for the body with the launch of its first device, the Lipo Wrap, offers wearable, portable gear that makes it possible to achieve expensive and time-consuming spa results in the comfort and convenience of home at an affordable price. The company's high-tech wellness devices aim to help customers achieve weight loss, pain relief, skin rejuvenation, hair growth, better sleep, less stress & more. For more information and to view the entire portfolio of high-tech devices, visit www.nushape.com. 

Sign up for Nushape's free newsletter today.

1  https://pubmed.ncbi.nlm.nih.gov/23626925

2 https://pubmed.ncbi.nlm.nih.gov/24286286

3  https://pubmed.ncbi.nlm.nih.gov/23626925

4  https://pubmed.ncbi.nlm.nih.gov/24028507

5 https://pubmed.ncbi.nlm.nih.gov/24551842

6 https://link.springer.com/article/10.1007/s10103-019-02867-5

7 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215986

Contact Information:
Leslie Carlson
COO
[email protected]


Original Source: Nushape Unveils the Therapy Mat: Your Ultimate Portable Partner for Holistic Wellness

Dr. Marc Napp to Lead The Trajectories Company

By
NT Editor
-
0
Dr. Marc Napp to Lead The Trajectories Company

FORT LAUDERDALE, Fla., August 18, 2023 (Newswire.com) - Outcome Engenuity (OE) is excited to announce the appointment of Dr. Marc Napp to lead The Trajectories Company as its chief executive officer. Trajectories is a unique firm created to complement the expertise of OE's other subsidiary, The Just Culture Company. Together, Trajectories and Just Culture provide an industry-leading set of tools and resources to address the risks present in socio-technical systems. Where Just Culture tackles issues of human error, poor decision-making, and free will by creating accountability models for the workplace, Trajectories takes those models and incorporates them into redesigning processes and systems to propel workplace safety and organizational performance.

Before taking the helm at The Trajectories Company, Marc held senior executive leadership positions at the Mount Sinai Health System, Northwell Health, and Memorial Healthcare System. Over the course of his administrative career, he has been responsible for a wide range of operational areas, including medical staff affairs, quality and patient safety, risk management, physician leadership development, medical education, emergency management, clinical resource management, health information management, and medical ethics. Marc's academic credentials include a Bachelor of Science in Engineering with honors from Princeton University and a medical degree from the Albert Einstein College of Medicine. To advance his interests in systems management, he obtained a master's degree in administrative medicine from the University of Wisconsin-Madison.

"Dr. Napp knows healthcare. But we hired him because he's an engineer. He lives and breathes system design and workplace culture," said David Marx, CEO of Outcome Engenuity. "I can think of no one better suited to helping our clients improve operational performance." 

------------------------------

The Trajectories Company is a system and process design company. Through its risk visualization software and the strength of its advisor team, it helps high-consequence organizations reduce the risk of adverse events. Learn more at www.trajectoriescompany.com.

Contact Information:
Michelle Karoly
Media Relations
[email protected]
954-228-0245


Original Source: Dr. Marc Napp to Lead The Trajectories Company

Amber Ophthalmics Announces First Patient Enrolled in NEXPEDE-1, a Phase 2/3 Clinical Trial Evaluating Nexagon for the Treatment of Persistent Corneal Epithelial Defects

By
NT Editor
-
0
Amber Ophthalmics Announces First Patient Enrolled in NEXPEDE-1, a Phase 2/3 Clinical Trial Evaluating Nexagon for the Treatment of Persistent Corneal Epithelial Defects

SAN DIEGO, August 18, 2023 (Newswire.com) - Amber Ophthalmics, Inc. (Amber), a privately held, clinical stage biopharmaceutical company, announced today that Dr. Mark S. Gorovoy from Gorovoy M.D. Eye Specialists has enrolled the first patient in the AMB-01-006 (NEXPEDE-1) study. The NEXPEDE-1 study is a randomized, double-masked, vehicle-controlled Phase 2/3 clinical trial designed to evaluate two concentrations of Nexagon® (lufepirsen ophthalmic gel) for the treatment of persistent corneal epithelial defects (PCED) (ClinicalTrials.gov identifier: NCT05966493).

This study evaluates the safety and efficacy of Nexagon, in a dosing regimen that utilizes as few as five topical in-office administrations for subjects with confirmed non-infectious PCED. Subjects who do not re-epithelialize within the first four weeks of treatment will continue to receive weekly administrations until subjects either achieve re-epithelialization or complete eight weeks of therapy. The primary endpoint for the NEXPEDE-1 study will be complete corneal healing as determined by corneal fluorescein staining. 

"We are excited to have enrolled the first subject into the NEXPEDE-1 study and are fortunate to have a strong contingency of clinical sites dedicated to the treatment of PCED," said Dr. Shawn A. Scranton, President and CSO of Amber. "We look to expeditiously complete this study, as it will further guide the development of this first-in-class PCED therapy that we believe can address a variety of the underlying PCED etiologies."  

LUFEPIRSEN OPHTHALMIC GEL (NEXAGON) is a patent-protected, unmodified antisense oligonucleotide that inhibits connexin43 protein translation, a cell membrane hemichannel forming protein associated with ocular inflammation and progression of PCED disease pathology. As a result of Nexagon's unique mechanism of action, the medication may be administered topically in the office by the physician at a frequency far less than the current treatment paradigm consisting of multiple daily patient-administered drops. 

ABOUT AMBER OPHTHALMICS

Amber Ophthalmics, Inc. is a privately held, clinical-stage biopharmaceutical company focused on innovative therapies for rare ophthalmic diseases. We are committed to addressing unmet medical needs for the restoration, preservation and improvement of patient vision and quality of life. For more information, visit amberophthalmics.com or LinkedIn for updates.

ABOUT PERSISTENT CORNEAL EPITHELIAL DEFECTS (PCED)

PCED is a rare and progressive disease impacting ~100,000 patients in the United States per year that arises from the failure of corneal re-epithelialization within 10-14 days of a corneal insult, even with the use of standard supportive treatment. Despite treatment, and regardless of underlying etiology if progression is not halted, PCED can result in corneal scarring, vascularization and/or severe vision loss. There are currently no FDA-approved therapies for the treatment of PCED, with many patients progressing to corneal transplant. 

Contact Information:
Jill Jene, PhD
CBO, Amber Ophthalmics
[email protected]


Original Source: Amber Ophthalmics Announces First Patient Enrolled in NEXPEDE-1, a Phase 2/3 Clinical Trial Evaluating Nexagon for the Treatment of Persistent Corneal Epithelial Defects

Criterion preps massive Jackie Chan box set featuring early films

By
NT Editor
-
0
Criterion preps massive Jackie Chan box set featuring early films

The Criterion Collections is prepping a massive box set of Jackie Chan’s early movies, but the selection may puzzle die hard fans.

Jackie Chan is about to get a major new collection from Criterion, with the prestige label announcing a new set called Jackie Chan: Emergence of a Superstar. The set will contain a few of Chan’s early classics, including Fearless Hyena (and its sequel) and The Young Master, as well as a later film, My Lucky Stars, and a pair of his earliest vehicles, Half a Loaf of Kung Fu and Spiritual Kung Fu. Fans of Chan’s may be scratching their heads at a few of the titles, as outside of Young Master and Fearless Hyena, none of the films included in the set are considered his best work.

It seems like rights issues are keeping legit early classics like Drunken Master off the set, with the most puzzling choice being to include Fearless Hyena 2, which is really little more than a curiosity for fans. Chan notoriously quit the film halfway through production after leaving his contract with producer Lo Wei, leaving the film to be finished with doubles.

That said, the set is set to be jam-packed with extras, including commentary tracks, interviews, alternate audio tracks (including a mix of vintage English dubbed tracks and newly created ones) and even, in the case of The Young Master, a Cannes Promo Reel that has some deleted footage.

Criterion previously released Police Story I & 2 as a well-received double set, and hopefully, this sells well enough that some of his legitimate classics get the Criterion treatment. Dragons Forever, Wheels on Meals, and some of his other Golden Harvest era movies, especially Drunken Master 2, deserve the Criterion treatment more than most of the movies in this set. Project A and Project A Part 2 are crying out for a new re-release in North America. Still, an issue used to be that The Weinstein Company had the rights to many Hong Kong classics, including most John Woo movies, explaining why none of those have ever gotten the prestige releases they deserve. It would be nice to see the much more deserving Hong Kong classics from Chan and his contemporaries get their day in the sun, as there are a lot of great movies out there that are out of circulation.

Originally published at https://www.joblo.com/criterion-preps-massive-jackie-chan-box-set-featuring-early-films/

The Toxic Avenger remake unveils first image of Peter Dinklage and teaser art!

By
NT Editor
-
0
The Toxic Avenger remake unveils first image of Peter Dinklage and teaser art!

With The Toxic Avenger remake set to premiere at Fantastic Fest, the first image and some teaser art have arrived online

Two years have passed since filming wrapped on writer/director Macon Blair’s remake of the Troma cult classic The Toxic Avenger (watch it HERE), and now the movie is finally about to make its way out into the world! We still don’t have a release date, but we do know The Toxic Avenger is going to have its world premiere at Fantastic Fest next month – and along with the news of that screening comes the unveiling of the first image of Peter Dinklage as the title character, and a bit of teaser art! You can check them out at the bottom of this article.

Sure, Dinklage’s Toxie is shrouded in shadow in the image, but it’s still more than we’ve seen of him up to this point. The teaser art comes courtesy of our friends at Bloody Disgusting.

Blair’s version of The Toxic Avenger stars Dinklage as Winston Gooze, a stereotypical weakling who works as a janitor at Garb-X health club and is diagnosed with a terminal illness that can only be cured by an expensive treatment that his greedy, power hungry employer refuses to pay for. After deciding to take matters into his own hands and rob his company, Winston falls into a pit of toxic waste and is transformed into a deformed monster that sets out to do good and get back at all the people who have wronged him.

Dinklage is joined in the cast by Jacob Tremblay (presumably as Winston’s son), Taylour Paige as the “female lead” (we haven’t heard any details on her character), Julia Davis and Elijah Wood as unspecified characters, Jonny Coyne as a “shadowy criminal figure”, Sarah Niles as a “corrupt city official”, and Kevin Bacon as the primary villain, a role Wood had originally been rumored for. Blair is also in the cast as a guy named Dennis.

According to The Illuminerdi, the main villain is rumored to be Bob Garbinger – Leonine hair and eerie plastic surgery. Evil head of the shady company Garb X. He has no regard for the well being of anyone but himself and embarks on a murderous spree to become as powerful as Toxie. His ego is bolstered by his standing amongst the towns official but in reality he lives in fear of the underworld gang he’s indebted to.

The Toxic Avenger remake was filmed in Bulgaria. Troma’s Lloyd Kaufman and Michael Herz produced with Legendary Entertainment. The film has received an R rating for “strong violence and gore, language throughout, sexual references and brief graphic nudity“ – and the gore includes a moment that has been referred to as “the butt guts scene“.

Are you looking forward to The Toxic Avenger remake? Let us know by leaving a comment below… and while you’re scrolling down, take a look at the first image and the teaser art.

The Toxic Avenger remake unveils first image of Peter Dinklage and teaser art!
The Toxic Avenger remake



Originally published at https://www.joblo.com/toxic-avenger-image/

Heart of Stone tops the Netflix charts as Hidden Strike fades

By
NT Editor
-
0
Heart of Stone tops the Netflix charts as Hidden Strike fades

Netflix’s Heart of Stone topped the global and U.S top 10 this week as the surprise hit Jackie Chan movie, Hidden Strike, fell off the U.S chart.

It looks like the obscure and long-shelved Jackie Chan/ John Cena vehicle Hidden Strike’s reign at the top of the Netflix charts is over, with Gal Gadot’s spy thriller Heart of Stone topping the global charts. Curiously, Hidden Strike, while still coming in at number 2 on the international charts, completely fell out of the top 10 on the U.S. chart, which seems strange considering how well it did last week (read our review of the underwhelming film here).

Gal Gadot’s mostly well-reviewed Heart of Stone raked in 33.1 Million views and 69.6 hours viewed. While promising, that puts the movie well behind a pair of Netflix’s most recent action flicks, Extraction 2, which raked in 88.4 hours viewed in its first week, and The Mother, which was watched for 83.7 hours. In fact, the latter film, which stars Jennifer Lopez, has turned into Netflix’s biggest hit of the year, currently sitting at number 7 on their all-time Most Popular Films chart. No other 2023 movie has managed to duplicate that feat, including the much-hyped Extraction 2.

Meanwhile, on the T.V. side, Peter Berg’s opioid limited series Painkiller has proven to be a hit, with it topping the charts despite its grim subject matter. Based on the Sackler family’s development of OxyContin, the series earned 7.2 million views. That’s pretty good for such a heavy show, and it looks like the Uzo Aduba, Taylor Kitsch, and Matthew Broderick-led series is a solid hit. Hopefully, its success will encourage Netflix to make more limited series like these. There’s plenty of room for fun and fantasy, but sometimes harder-hitting stuff should be on the menu too.

Sadly, it looks like Netflix’s They Cloned Tyrone never made much of a dent on the charts, with it falling out of the global and U.S. top 10 this week. Perhaps it was too off-kilter for the mainstream Netflix audience but good on them for taking a chance on riskier material.

Did you watch Heart of Stone or Painkiller this weekend? Let us know what you think in the comments!

Originally published at https://www.joblo.com/heart-of-stone-tops-the-netflix-charts-as-hidden-strike-fades/

Curitics Health Launches Innovation Hub for Value-Based Care

By
NT Editor
-
0
Curitics Health Launches Innovation Hub for Value-Based Care
Hub is central to the development of the company's low-code platform - Curitics Pulse 3.0


Curitics Health
Curitics Health Logo

WEST COVINA, Calif., August 17, 2023 (Newswire.com) - This week, Curitics Health announced the launch of its new delivery center, home to top-tier talent dedicated to addressing the crucial technology issues surrounding value-based care. This center, based in Noida, India, is home to the development of the company's state-of-the-art, low-code platform, Curitics Pulse 3.0, designed to improve the value-based care landscape significantly.

Value-based care is a healthcare delivery model where providers are paid based on patient health outcomes rather than the quantity of healthcare services delivered. While the shift from fee-for-service to value-based care has many potential benefits, such as improving patient health and reducing healthcare costs, there are also significant challenges, including data management, patient engagement and care coordination.

Curitics is poised to solve these challenges through:

Data Management - The transition to value-based care necessitates seamless integration and sharing of vast amounts of data among various stakeholders. Curitics' cutting-edge data management system enables efficient data exchange and incorporates advanced analytics to provide insights into patient care and costs.

Patient Engagement - Curitics empowers patients to take a more active role in their care. Through its patient portal, patients have access to their health information and educational materials and can directly communicate with their care team, promoting a more proactive and personalized healthcare experience.

Care Coordination - Coordinating care among various healthcare providers is often complex and challenging. Curitics simplifies this process by providing a unified platform where providers can share patient information, communicate effectively and jointly develop care plans.

"Curitics represents a revolutionary step forward in the approach to value-based care," says Chris Pempsell, co-founder and chief product officer at Curitics Health. "By combining the most advanced technology with top-tier talent, we're creating a platform that will enable healthcare providers to deliver better outcomes for their patients and improve the overall efficiency of their operations."

Curitics partners with healthcare organizations to rapidly develop in-clinic and virtual care programs that enrich patient care, improve provider experience and meet the dynamic needs of health plan payors. Initial service offerings support health plan payors, virtual care providers and home health vendors and will eventually expand to include behavioral health providers, managed service organizations (MSOs) and disease-specific program vendors for diabetes, chronic heart failure and COPD.

About Curitics Health

Curitics Health is a technology company that supports value-based healthcare organizations for better patient outcomes, increased provider satisfaction and improved health plan operations. For more information, visit curiticshealth.com. 

Contact Information:
Regina Vaccari
Owner/Principal, Vaccari Communications
[email protected]
(702) 337-1781


Original Source: Curitics Health Launches Innovation Hub for Value-Based Care

Hearts of Darkness: epic documentary on Jason Goes to Hell is almost finished

By
NT Editor
-
0
Hearts of Darkness: epic documentary on Jason Goes to Hell is almost finished

Hearts of Darkness: epic documentary on Jason Goes to Hell is almost finished

Originally published at https://www.joblo.com/jason-goes-to-hell-doc/

VetVerifi and Bitwerx Announce Partnership, Transforming Health Data Verifications for the Pet Economy

By
NT Editor
-
0
VetVerifi and Bitwerx Announce Partnership, Transforming Health Data Verifications for the Pet Economy
VetVerifi and Bitwerx join forces with a strategic investment and partnership to build the future of how the pet economy securely verifies health data, better connecting veterinarians with their pet care partners.


VetVerifi and Bitwerx Join Forces
VetVerifi and Bitwerx Announce Strategic Partnership

NASHVILLE, Tenn., August 17, 2023 (Newswire.com) - VetVerifi Inc., a technology company specializing in innovative data solutions for the pet care economy, and Bitwerx, Inc., an industry-leading software company focused on providing data-driven health benefitting the veterinary market, practice and veterinary healthcare teams, proudly announce their strategic investment and partnership aimed at transforming the landscape of pet health data management.

The collaboration brings together VetVerifi's cutting-edge technologies and Bitwerx's trusted expertise in veterinary data systems, data standardization and connectivity, providing a powerful synergy that will streamline and enhance the way veterinary professionals securely enable heath data access to their pet care partners from pet services to housing to the workplace.

VetVerifi co-founder and Partner Tim Ridgway expressed enthusiasm for the partnership, stating, "We are thrilled to embark on this journey with Bitwerx. Our shared vision of leveraging technology to improve outcomes in clinical and non-clinical applications aligns perfectly, and this collaboration will undoubtedly revolutionize how veterinarians efficiently and securely collaborate with their partners who rely on the access to vital pet health data daily."

Likewise, Bitwerx co-founder and CEO Jason Jaggers conveyed excitement about the partnership. "Bitwerx is excited to team up with VetVerifi. Our veterinary data expertise and capabilities combined with their verification technology will empower veterinarians to make better-informed decisions while enhancing communication and engagement across the pet economy."

The strategic investment and partnership between VetVerifi and Bitwerx signifies a groundbreaking moment for the pet care industry. Both companies are committed to creating a digital infrastructure that seamlessly integrates with existing veterinary practice management systems, making pet health data more accessible, secure, and actionable for the organizations that rely on verified patient records every day.

Financial terms of the deal were not disclosed. As a result of this collaboration, Bitwerx joins VetVerifi's board of directors, cementing their commitment to driving future growth and innovation in the pet care economy. 

About VetVerifi: VetVerifi is a data and technology company at the forefront of developing innovative solutions for the pet care market, better connecting veterinarians with their pet care partners. Our mission is to make pet care collaboration better beyond the clinic. To learn more, visit https://vetverifi.com.

About Bitwerx: Bitwerx is a data-driven software company located in the heart of the Bluegrass. With deep and broad knowledge in the veterinary and dental markets, our team of data nerds, coders, and industry experts helps partners leverage practice data to improve medical outcomes, practice profitability, and the customer journey. To learn more, visit https://bitwerx.com.

For media inquiries or more information, please contact: 

David Servodidio
Co-Founder & Partner
VetVerifi Inc.
[email protected]

Contact Information:
David Servodidio
Co-Founder & Partner
[email protected]


Original Source: VetVerifi and Bitwerx Announce Partnership, Transforming Health Data Verifications for the Pet Economy
1...244245246...579Page 245 of 579
© Newsmag WordPress Theme by TagDiv